-
Europe on high alert as Coronavirus (Covid-19) spread intensifies
pharmaceutical-technology
March 04, 2020
European countries are on high alert as coronavirus (Covid-19) is spreading rapidly across the region.
-
Applied DNA, Takis Biotech design four Covid-19 vaccine candidates
pharmaceutical-technology
March 04, 2020
Applied DNA Sciences and Takis Biotech have designed four Covid-19 vaccine candidates to help protect against the novel coronavirus.
-
Mateon launches antiviral programme focused on Covid-19
pharmaceutical-technology
March 04, 2020
Mateon Therapeutics has launched an antiviral response programme that will initially focus on Covid-19 disease caused by the novel coronavirus.
-
New findings show SARS drugs can help treat Covid-19
pharmaceutical-technology
March 04, 2020
Researchers in the US have mapped a SARS-CoV-2 protein, which could help use drugs developed to treat SARS coronavirus as effective treatments for the new Covid-19 disease.
-
Novavax starts animal testing of coronavirus vaccine candidates
pharmaceutical-technology
March 03, 2020
US-based biotechnology company Novavax has begun testing its new coronavirus vaccine candidates in animal models.
-
Coronavirus deaths cross 3,000; recovery rate in China rises
pharmaceutical-technology
March 03, 2020
The total number of deaths due to coronavirus (Covid-19) has crossed 3,000, as of the end of 1 March. The number of deaths in mainland China stands at 2,912.
-
NIAID Began First Clinical Trial of Remdesivir in the U.S.
Lin Zhang
March 03, 2020
An Investigational New Drug Application (IND) Remdesivir is developed by American drugmaker Gilead Sciences Inc..
-
WuXi Biologics, Vir Biotech Partner to Develop COVID-19 Antibodies
contractpharma
March 03, 2020
WuXi Biologics will conduct cell-line development, process and formulation development, and initial manufacturing for clinical development.
-
Novavax Advances Development of COVID-19 Vaccine
contractpharma
March 03, 2020
Novavax, Inc., a late-stage biotechnology company developing next-gen vaccines for serious infectious diseases, has advanced its efforts to develop a novel vaccine to protect against coronavirus disease COVID-19.
-
Why the U.S. is "Flying in the Dark" Without Quicker Ability to Diagnose COVID-19
Prnewswire
March 03, 2020
Active companies in the markets this week include Hawkeye Systems, Inc. (OTCQB: HWKE), Novavax, Inc. (NASDAQ: NVAX), Generex Biotechnology Corporation (OTCQB: GNBT), Vaxart, Inc. (NASDAQ: VXRT), iBio, Inc. (NYSE: IBIO).